Home › Funds › United Asset Strategies, Inc. › EW

United Asset Strategies, Inc. position in EW

EDWARDS LIFESCIENCES CORP · Health Care

United Asset Strategies, Inc. reported holding 195,672 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$16.9M, representing 1.16% of its reported portfolio and ranking #23 among its reported holdings. United Asset Strategies, Inc. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)195.67K sh
Reported value held$16.89M
Portfolio Weight1.16%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How United Asset Strategies, Inc.'s EW position evolved

United Asset Strategies, Inc. first disclosed a stake in EW in Q3 2023 at 7,981 shares (US$553K). The position peaked in Q2 2026 at 192,582 shares, worth US$17.4M. Across 13 filings, United Asset Strategies, Inc. increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 195,672 shares valued at US$16.9M — an increase of 3,090 shares quarter over quarter.. Notable position changes include a 1550% increase in Q1 2024 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.98K $552.92K New
Q4 2023 9.12K $695.63K Add
Q1 2024 150.51K $14.38M Add
Q2 2024 153.79K $14.21M Add
Q3 2024 159.92K $10.55M Add
Q4 2024 168.16K $12.45M Add
Q1 2025 185.57K $13.45M Add
Q2 2025 186.62K $14.60M Add
Q3 2025 189.31K $14.72M Add
Q4 2025 191.75K $16.35M Add
Q1 2026 193.86K $15.52M Add
Q2 2026 192.58K $17.42M Reduce
Q3 2026 195.67K $16.89M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has United Asset Strategies, Inc. held EW?

United Asset Strategies, Inc. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is United Asset Strategies, Inc.'s current position in EW?

As of Q3 2026, United Asset Strategies, Inc. holds 195.67K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $16.89M, representing 1.16% of its reported portfolio and ranking #23.

Has United Asset Strategies, Inc. been buying or selling EW?

In the latest 13F filing (Q3 2026), United Asset Strategies, Inc. increased its position in EW. The position peaked in Q2 2026 at 192.58K shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.